Results
1
1 companies
argenx
Market Cap: €42.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€682.00
7D
5.4%
1Y
33.6%
